Internal Medicine, Rheumatology · Willow Grove, PA
NPI
1548247679
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
2360 Maryland Rd
Willow Grove, PA, 19090
Phone (215) 657-6776
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.1M
245,781 services
Medicare patients, 2024
1,037
Average age 73
Drug cost, 2024
$3.1M
7,246 prescriptions
Company payments, 2025
$3,711
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Chesner was code J3262 (injection, tocilizumab, 1 mg), 78,640 times for 35 patients. In total David J Chesner billed 245,781 services in 65 codes, and Medicare paid $3.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 78,640 | 35 | $4.70 | $369K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 59,200 | 43 | $3.60 | $213K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 25,200 | 46 | $8.56 | $216K |
| J0897 Injection, denosumab, 1 mg | Office | 18,600 | 261 | $20.63 | $384K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 14,636 | 39 | $9.07 | $133K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 10,650 | 41 | $33.80 | $360K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 4,860 | 40 | $24.84 | $121K |
| J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 4,270 | 13 | $37.89 | $162K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,650 | 95 | $0.10 | $372 |
| J9312 Injection, rituximab, 10 mg | Office | 2,840 | 17 | $61.14 | $174K |
| J7325 Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 1,296 | 16 | $7.07 | $9,166 |
| 99214 Office E&M - Established | Office | 1,206 | 569 | $95.46 | $115K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 948 | 469 | $12.21 | $12K |
| 96401 Chemotherapy Administration | Office | 839 | 337 | $59.01 | $50K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 532 | 120 | $0.75 | $400 |
By year: 2022 $1.9M for 108,655 services; 2023 $2.0M for 140,343 services; 2024 $3.1M for 245,781 services.
Medicare prescription drug claims, 2024
In 2024, the drug David J Chesner prescribed most often to Medicare patients was Prednisone, with 483 prescriptions and refills. In total David J Chesner wrote 7,246 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 483 | 772 | 114 | $4,521 |
| Hydroxychloroquine Sulfate Generic | 402 | 734 | 97 | $17K |
| Tramadol Hcl Generic | 350 | 382 | 67 | $2,174 |
| Gabapentin Generic | 336 | 617 | 93 | $5,572 |
| Methylprednisolone Generic | 226 | 275 | 83 | $3,692 |
| Celecoxib Generic | 212 | 396 | 56 | $5,273 |
| Duloxetine Hcl Generic | 210 | 513 | 52 | $6,736 |
| Methotrexate Methotrexate Sodium | 207 | 440 | 54 | $4,176 |
| Alprazolam Generic | 190 | 195 | 30 | $1,180 |
| Meloxicam Generic | 155 | 321 | 44 | $499 |
| Cyclobenzaprine Hcl Generic | 137 | 196 | 32 | $1,476 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 128 | 128 | 26 | $4,175 |
| Clonazepam Generic | 123 | 135 | 18 | $788 |
| Pregabalin Generic | 111 | 156 | 24 | $2,759 |
| Lorazepam Generic | 103 | 107 | 17 | $413 |
Brand drugs: 582 claims; generic drugs: 6,648 claims; opioid claims: 798.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Chesner $3,711 ($3,711 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $508.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 16 | $508 |
| Amgen Inc. AMGN | 30 | $492 |
| Abbvie Inc. ABBV | 17 | $432 |
| UCB, Inc. UCB.BR | 11 | $398 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $283 |
| Janssen Biotech, Inc. JNJ | 11 | $231 |
| Mallinckrodt Hospital Products Inc. | 5 | $168 |
| ANI Pharmaceuticals, Inc. ANIP | 8 | $158 |
| Radius Health, Inc. | 6 | $155 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $153 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.